ArticlePharmacoEconomics2015

A practical guide for using registry data to inform decisions about the cost effectiveness of new cancer drugs: lessons learned from the PHAROS registry.

Hedwig M Blommestein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.